Vega-López F, Brooks L A, Dockrell H M, De Smet K A, Thompson J K, Hussain R, Stoker N G
Department of Clinical Sciences, London School of Hygiene and Tropical Medicine, United Kingdom.
Infect Immun. 1993 May;61(5):2145-53. doi: 10.1128/iai.61.5.2145-2153.1993.
Sera from lepromatous leprosy patients were used to screen a Mycobacterium leprae lambda gt11 library. Three positive plaques were picked, and lysogens were constructed. Immunoblot analysis showed that all of the lysogens expressed an apparently identical beta-galactosidase fusion protein which reacted strongly with the sera. The 1.7-kbp insert from one clone was subcloned into the lacZ gene in pUR290; sequence analysis of the end fused to lacZ revealed an open reading frame with no significant homology to previously published sequences. The insert was used to screen an M. leprae cosmid library, and five clones were isolated. The insert was also found to hybridize to clones expressing the M. leprae antigen which had previously been designated class III and 25L. A 1.8-kbp HindIII fragment was subcloned from one of the cosmids and sequenced. The sequence revealed a 1,227-bp open reading frame, encoding a 408-amino-acid protein with a predicted molecular mass of 42,466 Da. The protein contains amino- and carboxy-terminal hydrophobic domains and a hydrophilic central domain; the amino-terminal domain shows some homology to a 51-kDa hypothetical antigen of Mycobacterium tuberculosis, while the hydrophilic region contains a high proportion of serine residues, and we have therefore designated the protein serine-rich antigen (Sra). Some repeated motifs are present in the protein, but their significance is unknown. Seventy-eight percent of serum samples from multibacillary leprosy patients and 68% of serum samples from paucibacillary leprosy patients recognized the fusion protein, showing that this is a major M. leprae antigen. In contrast, all serum samples from endemic controls were negative, while 26% of serum samples from tuberculosis patients were weakly positive.
用瘤型麻风患者的血清筛选麻风分枝杆菌λgt11文库。挑选出三个阳性噬菌斑,并构建溶原菌。免疫印迹分析表明,所有溶原菌均表达一种明显相同的β-半乳糖苷酶融合蛋白,该蛋白与血清反应强烈。将一个克隆的1.7kb插入片段亚克隆到pUR290的lacZ基因中;与lacZ融合的末端序列分析显示一个开放阅读框,与先前发表的序列无明显同源性。该插入片段用于筛选麻风分枝杆菌黏粒文库,并分离出五个克隆。还发现该插入片段与表达先前被指定为III类和25L的麻风分枝杆菌抗原的克隆杂交。从其中一个黏粒中克隆出一个1.8kb的HindIII片段并进行测序。序列显示一个1227bp的开放阅读框,编码一个408个氨基酸的蛋白质,预测分子量为42466Da。该蛋白质含有氨基和羧基末端疏水结构域以及一个亲水中心结构域;氨基末端结构域与结核分枝杆菌的一种51kDa假想抗原有一定同源性,而亲水区域含有高比例的丝氨酸残基,因此我们将该蛋白质命名为富含丝氨酸抗原(Sra)。该蛋白质中存在一些重复基序,但其意义尚不清楚。多菌型麻风患者78%的血清样本和少菌型麻风患者68%的血清样本识别该融合蛋白,表明这是一种主要的麻风分枝杆菌抗原。相比之下,地方性对照的所有血清样本均为阴性,而结核病患者26%的血清样本呈弱阳性。